Loading...
Market
Adoption level of WHO's new terminology by major health organizations by end of 2024
5
Resolution / Starting Odds
Widely adopted • 25%
Moderately adopted • 25%
Rarely adopted • 25%
Not adopted • 25%
Official statements or adoption notices from major global health organizations like CDC, ECDC, AfricaCDC.
Story
WHO Renames Airborne Viruses as 'Pathogens That Transmit Through the Air'
Apr 18, 2024, 11:11 AM
The World Health Organization (WHO) has introduced new terminology for airborne viruses, now to be referred to as 'pathogens that transmit through the air.' This update, published in a global technical consultation report, aims to resolve a scientific disagreement that negatively impacted the initial response to Covid-19. The revised terminology is the outcome of a multi-year collaborative effort involving WHO, about 500 experts, advisory members, including co-chairs Dr. Yuguo Li and Dr. Gagandeep Kang, and organizations like @AfricaCDC. However, some experts, like Trish Greenhalgh, criticize the new terms, such as 'puff cloud,' as a retrograde step.
View original story
Similar markets
Widespread adoption in multiple continents • 25%
Adopted in Europe only • 25%
Adopted in North America only • 25%
No significant adoption • 25%
North America • 25%
Europe • 25%
Asia • 25%
Australia • 25%
Support • 33%
Criticism • 33%
Neutral • 33%
Fully adopted • 25%
Moderately adopted • 25%
Rarely adopted • 25%
Not adopted • 25%
Low adoption (few countries) • 25%
Moderate adoption (some countries) • 25%
High adoption (many countries) • 25%
Very high adoption (most major livestock countries) • 25%
Widely adopted in over 50 countries • 25%
Adopted in 20-50 countries • 25%
Adopted in less than 20 countries • 25%
Not adopted widely • 25%
Widely adopted • 25%
Moderately adopted • 25%
Rarely adopted • 25%
Not adopted • 25%
Yes • 50%
No • 50%
Less than 10 • 33%
10-20 • 34%
More than 20 • 33%
Broad adoption • 25%
Selective adoption • 25%
Minimal adoption • 25%
No adoption • 25%
Widely included • 33%
Occasionally referenced • 33%
Rarely referenced • 34%
Complexity of the policy • 33%
Narrow definition of potential pandemic pathogen • 33%
Lack of comprehensive risk-benefit analysis • 33%